Strategic collaborations Leverage CNIO's strong network with hospitals through its 5 Clinical Research Units and 19 Core Units to offer data-driven clinical trial support, translational research services, and collaborations for experimental therapeutics programs.

Data and analytics CNIO’s involvement in data sharing initiatives like the National Cancer Data Node and alignment with FAIR principles presents an opportunity to offer data management, analytics, and interoperability solutions tailored to cancer research workflows.

Drug discovery synergy With an Experimental Therapeutics program focused on academic drug discovery, there is potential to propose collaborations around rapid lead optimization, preclinical studies, and access to in-house assay platforms and expert personnel.

Global visibility CNIO’s international engagements and recognition as a Severo Ochoa Centre of Excellence, plus partnerships highlighted in recent press, create openings for co-funded research initiatives, technology licensing, and joint grant opportunities.

Strategic funding RevenueScope indicates mid-range funding and public sponsorship; opportunities exist to position services for grant-backed programs, large-scale datasets, and multi-institutional research consortia targeting cancer diagnostics, treatment, and precision medicine.